Blood doping
| Reference number | |
| Coordinator | Umeå Biotech Incubator AB |
| Funding from Vinnova | SEK 551 000 |
| Project duration | December 2013 - June 2014 |
| Status | Completed |
Important results from the project
Through having collected the stipulated samples from doped athletes both at low and high altitudes, the purpose of an extended analytical material was met. Furthermore, interviews with sponsors provided an understanding for future marketing, which fulfills the aim of future investors. A great deal of interest among investors proved achievement.
Expected long term effects
A total of 14 people have been tested for maximal exercise capacity (VO2max) and a transfusion of two units own, freez-storedt blood performed. Athletes in endurance sports has left pure, undoped control samples. A small group of elite athletes have provided blood samples before and after the stay and exercise at high altitude. Through a survey of potential sponsors six managers were interviewed regarding their anti-doping work in connection with the sponsorship.
Approach and implementation
The project has followed the project plan, that is WP1 Collect blood samples of doped and after altitude training, WP2 Analysis of blood samples by LC / MS / MS (in progress, complete in August 2014), WP3 Needs and Market Analysis of sponsors and WP4 Meet investors. We did not reach the desired number of doped samples (400), mostly due to some research participants chose to prematurely discontinue the study.